alexa

Search in Indianmoney's WealthPedia

 
Home News Alkem Labs acquires anti-nausea drug Marinol from AbbVie for $10 million

Read more interesting news from around the globe with Indianmoney App

Google Play
 
Get the Best Financial Advice on Travel InsuranceClick Here
 
 
Alkem Labs acquires anti-nausea drug Marinol from AbbVie for $10 million

Alkem Labs acquires anti-nausea drug Marinol from AbbVie for $10 million

Tuesday, December 31, 2019, 8:10 PM

Alkem Laboratories on December 31 announced that it is acquiring anti-nausea drug Marinol from US drug maker AbbVie for $10 million. Marinol, generically called as Dronabinol, is a man-made or synthetic form of marijuana (cannabis). Marinol capsules are used to treat the loss of appetite (anorexia) in AIDS patients and to treat nausea and vomiting in patients receiving chemotherapy.
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

What is your Credit Score? Get FREE Credit Score in 1 Minute!

Get Start Now!
CIBIL Meter
Get It now!
Attention!

This is to inform that Suvision Holdings Pvt Ltd ("IndianMoney.com") do not charge any fees/security deposit/advances towards outsourcing any of its activities. All stake holders are cautioned against any such fraud.